Background illustration for clinical trials search

Paid Clinical Trials Milwaukee

Discover 658 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

for
Follicular Lymphoma
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06794268

Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Milwaukee WI, Chicago IL, Iowa City IA, Farmington MI,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase 3, Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

for
Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, ATLL
Location: Milwaukee WI
Sponsor: Kyowa Kirin, Inc.

Sex: All

Age: 18+

Code: NCT04014374

Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Milwaukee WI, Chicago IL, Detroit MI, Nicholasville KY,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18+

Code: NCT07032662

Phase 2, Recruiting

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

for
Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis,
Location: Milwaukee WI, Durham NC, Chapel Hill NC, Boston MA,
Sponsor: UCB Biopharma SRL

Sex: Female

Age: 18+

Code: NCT06888193

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Milwaukee WI, Greenfield WI, Waukesha WI, Evanston IL,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Milwaukee WI, Madison WI, Chicago IL, Green Bay WI,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

for
Arthritis, Psoriatic
Location: Glendale WI, Windsor, Toronto, Orillia, Jonesboro AR,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06807424

Phase 3, Recruiting

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

for
Asthma
Location: Milwaukee WI, Normal IL, Cincinnati OH, Cleveland OH,
Sponsor: GlaxoSmithKline

Sex: All

Age: 12 - 17

Code: NCT05757102

Phase 3, Recruiting

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

for
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD
Location: Milwaukee WI, Columbus OH, Washington D.C. DC, Plano TX,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05966467

Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Milwaukee WI, Chicago IL, Iowa City IA, Ann Arbor MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for
Breast Cancer, Locally Advanced Breast Cancer,
Location: Milwaukee WI, Peoria IL, Urbana IL, Ann Arbor MI,
Sponsor: Olema Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07085767

Phase 3, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for
Clostridium Difficile, Clostridium Difficile Infections,
Location: Milwaukee WI, Gurnee IL, Burr Ridge IL, Ann Arbor MI,
Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase 3, Recruiting

A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

for
Cutaneous Sarcoidosis
Location: Milwaukee WI, Madison WI, Chicago IL, Ann Arbor MI,
Sponsor: Priovant Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06978725

Phase 2, Phase 3, Recruiting

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

for
Asthma
Location: Greenfield WI, Toledo OH, Bellevue NE, Asheville NC,
Sponsor: Biometry Inc

Sex: All

Age: 5 - 70+

Code: NCT07228026

Recruiting

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

for
Myasthenia Gravis
Location: Greenfield WI, Iowa City IA, Detroit MI, O'Fallon IL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06298565

Recruiting

A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

for
New Onset Generalized Myasthenia Gravis (gMG)
Location: Greenfield WI, Detroit MI, O'Fallon IL, Cleveland OH,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06909214

Recruiting

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

for
Ocular Myasthenia Gravis
Location: Greenfield WI, O'Fallon IL, Columbus OH, Amherst NY,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 18+

Code: NCT07463521

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Greenfield WI, Schaumburg IL, East Lansing MI,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase 3, Recruiting

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

for
Higher-risk Myelodysplastic Syndrome
Location: Milwaukee WI, Waukesha WI, Chicago IL, Rochester MN,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06641414

Phase 3, Recruiting